SCM
RETA

Sio Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Sio Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-43,842
Closed -$1.53M – 80
2018
Q2 		$1.53M Buy
+43,842
New +$1.34M 0.85% 35

Other funds holding RETA

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sio Capital Management's RETA Position: Q3 2018 in Review

Sio Capital Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2018, closing a stake of 43,842 shares — an estimated $1.53M sold.

Sio Capital Management first reported a position in RETA in Q2 2018 and held it in 1 quarter. The position peaked at $1.53M in Q2 2018. 119 funds tracked by Wall St. Rank hold RETA as of Q3 2018.

  • Sio Capital Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2018 after selling out during the quarter.
  • Sio Capital Management sold 43,842 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2018, an estimated $1.53M.
  • Sio Capital Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2018 and held it in 1 quarter.
  • Sio Capital Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.53M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2018.

Based on Sio Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.